MLS on the verge of breaking above that 31p high of April 2002. This was the item that triggered the current breakout last week:

LONDON (AFX) - Medical Solutions PLC, the cancer and pathology services
group, said The Doctors Laboratory, the leading provider of private cervical
screening in the UK, has stated that they are adopting Medical Solutions'
SurePath for their LBC screening.
The SurePath system will be supplied by Medical Solutions in the UK under
licence from TriPath Imaging Inc.
Medical Solutions chief executive Charles Green said the group now awaits
the NICE (the National Institute of Clinical Excellence) report issuing their
final guidance to the NHS, after their preliminary report recommended the use of
liquid based cytology within the NHS. This report is expected in September.
newsdesk@afxnews.com
slm/

See impressive bb comment here since then and on various BBs.

Interims due mid-Sept.
Ahead of a long weekend there might yet be some profit-taking, but with results and statements to come within the next 2-3 weeks I would guess most who are planning to do so will reduce rather than exit, and the effect will be perhaps be outweighed by new buyers waking up to what's happening.

MLS don't have the field to themselves with the nhs - there are still other contenders in the running. But it's looking hopeful in my opinion.

Company website

External Shareholders at 21 Aug 03:
89.15m 2p Ords - Edinburgh Fund Mgrs PLC 6.32%, INVESCO Asset Mgmt Ltd 5.78%, Prudential PLC 5.61%, Cantor Fitzgerald Europe 5.34%, Texas Group PLC 4.12%, Singer & Friedlander Inv 3.45%, Other Dirs 1.65%.

jzl

From FT today

Here is the link.

http://www.ft.com/cms/s/92381f54-54d6-11db-901f-0000779e2340.html

"SMALL-CAPS: MBO TALK LIFTS MEDICAL SOLUTIONS
By Robert Orr and Neil Hume

Published: October 6 2006 03:00 | Last updated: October 6 2006 03:00

*Talk of a management buy-out approach sent Medical Solutions 12.5 per cent higher to 6p. Shares in the healthcare technology group have failed to break through 10p for the best part of two years. It recently sold its Dubai pathology business for 12.9m, roughly equal to its present market value."


Rodders

On the up today and well bid, EVO's seem keen. DYOR

Rodders

On the up again today, with EVO's again aggresively on the bid, share price still below cash in the bank. EGM tomorrow to rubber stamp the sale of their Dubai opps. DYOR

Rodders